Information on efficacy of long-term antiretroviral treatment (ART) exposure in resource-limited countries is still scarce. In 767 patients attending routine HIV centers in Togo and receiving first-line ART for more than four years, 42% had viral load greater than 1000copies/ml and either were on a completely ineffective ART regime or were with only a single drug active. The actual conditions to ensure lifelong ART in resource-limited countries can have dramatic long-term outcomes
Background: We describe the accumulation of HIV-1 drug resistance and its effect on the activity of ...
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limit...
Background: In 1998, Senegal launched one of Africa's first anti-retroviral therapy (ART) programs. ...
Background: Access to antiretroviral treatment (ART) in resource-limited countries has increased sig...
Background: With widespread use of antiretroviral (ARV) drugs in Africa, one of the major potential ...
Background. The limited access to virological monitoring in developing countries is a major weakness...
International audienceAntiretroviral treatment (ART) has been scaled up over the last decade but com...
In the context of lifelong antiretroviral treatment (ART) as early as possible and to end the HIV/AI...
Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically reduced HIV-re...
Combination antiretroviral therapy (ART) has transformed HIV from a progressive, ultimately fatal il...
BACKGROUND: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
An observational study was conducted in Maputo, Mozambique, to investigate trends in prevalence of H...
Scale-up of antiretroviral therapy in low- and middle-income countries has been achieved by using a ...
Background: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
More than 11.7 million people are currently receiving antiretroviral therapy (ART) in low- and middl...
Background: We describe the accumulation of HIV-1 drug resistance and its effect on the activity of ...
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limit...
Background: In 1998, Senegal launched one of Africa's first anti-retroviral therapy (ART) programs. ...
Background: Access to antiretroviral treatment (ART) in resource-limited countries has increased sig...
Background: With widespread use of antiretroviral (ARV) drugs in Africa, one of the major potential ...
Background. The limited access to virological monitoring in developing countries is a major weakness...
International audienceAntiretroviral treatment (ART) has been scaled up over the last decade but com...
In the context of lifelong antiretroviral treatment (ART) as early as possible and to end the HIV/AI...
Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically reduced HIV-re...
Combination antiretroviral therapy (ART) has transformed HIV from a progressive, ultimately fatal il...
BACKGROUND: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
An observational study was conducted in Maputo, Mozambique, to investigate trends in prevalence of H...
Scale-up of antiretroviral therapy in low- and middle-income countries has been achieved by using a ...
Background: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
More than 11.7 million people are currently receiving antiretroviral therapy (ART) in low- and middl...
Background: We describe the accumulation of HIV-1 drug resistance and its effect on the activity of ...
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limit...
Background: In 1998, Senegal launched one of Africa's first anti-retroviral therapy (ART) programs. ...